Symbols

EIKN

Eikon Therapeutics·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About EIKN

Eikon Therapeutics, Inc.

A late-stage clinical biopharmaceutical company

Industry

Biological Technology

Established Date

07/09/2019

Listing Date

02/05/2026

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.eikontx.com

Security Type

Common stock

Office address

230 Harriet Tubman Way Millbrae California 94030

Business

Introduction

Eikon Therapeutics, Inc., was incorporated in Delaware on July 9, 2019. The company is a late-stage clinical biopharmaceutical company that develops innovative medicines to address significant unmet medical needs. The organization focuses primarily on oncology, advancing a range of drug candidates designed to meet high unmet needs in large indications. This leadership team has a remarkable history of successful development of impact drugs. The company's strategy includes leveraging proprietary technology platforms to create new therapies, with its main drug candidates targeting serious diseases such as advanced melanoma and non-small cell lung cancer.